Form 8-K ENANTA PHARMACEUTICALS For: Aug 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil falls 1% as investors watch Middle East supply disruptions
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Enanta Pharm (ENTA) Posts Mixed Q3 Results
August 11, 2014 9:23 AM EDTEnanta Pharm (NASDAQ: ENTA) reported Q3 EPS of $2.61, $0.94 better than the analyst estimate of $1.67. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $40.83 million.
For earnings history and earnings-related data on Enanta Pharm (ENTA) click here.
... More